Share this article
Share this article
SOUTH SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ PACT Pharma, Inc., a clinical-stage company developing transformational personalized neoTCR-T cell therapies for the eradication of solid tumors, today announced that the company will present at the 39
th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on January 11, 2021 at 7:30 a.m. PT/10:30 a.m. ET.
About PACT Pharma
PACT is a clinical-stage biopharmaceutical company pioneering individualized, non-viral precision genome engineered, tumor-specific T cell therapies for the treatment of patients with solid cancers. PACT is now enrolling patients in its first-in-human Phase 1 clinical trial.
Each person s cancer emerges with a private signature of mutations. PACT identifies these cancer mutation targets (neoantigens) for each person, biochemically verifies and captures T cells from their blood and uses its proprietary, cutting edge (non-viral) precision genome eng
Ibex Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, and
KSM, the Research and Innovation Center of Maccabi Healthcare Services – Israel s leading HMO - announced today a first-of-a-kind pilot of Ibex s Galen Breast solution for AI-powered primary diagnosis of breast cancer at Maccabi s Pathology Institute.
Breast cancer is the most common malignant disease in women worldwide, with over 2 million new cases each year. Early and accurate detection is critical for effective treatment and saving women s lives.
Maccabi KSM Logo
The pilot at Maccabi s Pathology Institute includes 2,000 breast biopsies on which pathologists will use Galen Breast as a First Read application. It is the first-ever deployment of an AI application for primary diagnosis of breast cancer.
The Rocky Mount Event Center is Certified Sensory Inclusive
KultureCity has partnered with the Rocky Mount Event Center to make the facility and all of the hosted programs and events to be sensory inclusive.
News provided by
Share this article
Share this article
ROCKY MOUNT, N.C., Jan. 7, 2021 /PRNewswire/ KultureCity has partnered with the Rocky Mount Event Center, located in Rocky Mount, North Carolina and operated by the Sports Facilities Companies, to make the facility and all of the venue s hosted programs and events sensory inclusive. Through training and a certification process, this new initiative will promote an accommodating, all-inclusive, and positive experience for all guests and fans that enter the state-of-the-art facility.
Parvizi Surgical Innovation Announces Investment and Partnership with PrecisionOS
Award-winning surgical simulation company, PrecisionOS, partners with internationally renowned group of orthopedic surgeons.
News provided by
Share this article
Share this article
PHILADELPHIA, Jan. 7, 2021 /PRNewswire/ Parvizi Surgical Innovation, LLC (PSI) is pleased to announce an investment and partnership with PrecisionOS™, a clinically-validated software company providing relevant medical-grade, interactive and industry-recognized virtual reality (VR) and augmented reality (AR) experiences for surgical training and education.
Founded by Danny P. Goel, MD, an orthopedic surgeon with a passion and commitment for novel educational approaches toward surgical mastery, PrecisionOS brings together a groundbreaking team of industry experts intersecting surgical education, gaming, and film with simulation and haptics.
Atsushi Sugita Succeeds Koichi Takagi as President & CEO of Maruho
USA - English
News provided by
Share this article
Share this article
OSAKA, Japan, Jan. 8, 2021 /PRNewswire/ Maruho Co., Ltd. (hereinafter Maruho ), based in Osaka, Japan, announced that its Board of Directors has named Atsushi Sugita Representative Director, President & CEO, effective December 18, 2020. Koichi Takagi has served as President & CEO since 1999 and remains as Chairman of the Board.
A native of Osaka, Japan, Sugita received his bachelor s degree in economics from Kyoto University in 1997, and went on to obtain an MBA from the Kellogg School of Management at Northwestern University in 2005. After working at Johnson & Johnson s U.S. headquarters and Janssen Japan, Sugita joined Maruho in 2012. After holding various positions at Maruho s R&D Labs, Head Office, and global subsidiaries, Sugita was elected to the Maruho Board in 2016, becoming Senior Corporate Officer in charge of Global Strategy and B